Whatever you've got to say about Google, it can't hear you over the sound of it banking $85m a day in pure profit • The Register
- TECHNOLOGY
- February 5, 2019
Activists are calling on the pharmaceutical firm Gilead Sciences to study a drug for the treatment of Covid-19 that showed promise in curing cats of a coronavirus. The drug, called GS-441524, is chemically related to remdesivir, an antiviral also made by Gilead, and one of the only treatments to successfully shorten the duration of Covid-19
READ MOREThe US Food and Drug Administration has revoked emergency use authorisations for anti-malaria drugs which President Donald Trump claimed without evidence could be used to treat Covid-19 as new research reveals potentially deadly side effects. Drugs like hydroxychloroquine and chloroquine flew off the shelves in recent months after they were touted by the US president
READ MOREThe first drug to treat Covid-19 has been approved in the UK, the Department of Health has said. Early data from clinical trials around the world showed remdesivir could shorten the recovery time of Covid-19 patients by four days. The Government said that the allocation of the drugs would be determined by where they would
READ MORETwo men have been arrested for drug driving after a British event rider was crushed under her horse and suffered life-changing injuries. Anna Tomson, 41, was put in an induced coma and on a ventilator in hospital after she was was thrown from her saddle on May 17. Her horse Berry, who weighs one-ton, was
READ MOREMachine-learning software to snare scammers hawking fake COVID-19 test kits on social media is being built by a tiny startup funded by the US National Institutes of Health. S-3 Research, founded by Timothy Mackey, an associate professor at the school of health sciences at the University of California, San Diego, was focused on sniffing out
READ MORESarcoma UK is disappointed to see that life extending cancer drug trabectedin (Yondelis) will not be made available routinely on the NHS to sarcoma patients in Scotland. Trabectedin, a chemotherapy drug which has been routinely available in the rest of the UK for over a decade, has been denied approval for regular use in Scotland
READ MORE